Astrazeneca Pharma Polandsp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Astrazeneca Pharma Poland is a biopharmaceutical company that develops and manufactures medicines for major challenges in modern medicine. Its therapeutic areas include oncology, cardiovascular and metabolic diseases, respiratory diseases, autoimmune conditions, neurological diseases, infectious diseases and vaccines.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2003-10-01. Active
43 1030 1508 0000 0005 0287 6007- 96 1030 1508 0000 0005 0287 6023
- 21 1030 1508 0000 0005 0287 6015
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 31, 2025 | Aid for research and development projects: experimental development | $1,687,095 | PIERWSZY MAZOWIECKI URZĄD SKARBOWY W WARSZAWIE |
Tenders
4 tenders recorded as contractor, with a total value of $7,497,699.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Sep 3, 2026 | Przetarg uzupełniający na dostawę do WCSKJ produktów leczniczych stosowanych w programach lekowych i chemioterapii | — | Wojewódzkie Centrum Szpitalne Kotliny Jeleniogórskiej | |
| Apr 14, 2026 | Zakup wraz z dostawą leków ogólnoszpitalnych dla Samodzielnego Publicznego Zakładu Opieki Zdrowotnej w Puławach, z podziałem na 83 części. | $3,431,364 | Samodzielny Publiczny Zakład Opieki Zdrowotnej w Puławach | |
| Nov 19, 2025 | Dostawa produktów leczniczych z programów lekowych oraz nowych produktów leczniczych | $3,393,610 | Copernicus Podmiot Leczniczy sp. z o.o. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
Each of the members of the management board is authorized to make declarations and sign documents on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Astrazeneca Continent B.v. | 99 | $13,371.15 | 2.475% |
Others | 3,901 | $526,877.36 | 97.525% |
Beneficial owners
| Person | Rights |
|---|---|
Marta Jagnieza (48)  | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Wiktor Jerzy Janicki (49) | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Barbara Kozierkiewicz (55) | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Edyta Wojtkiewicz (52) | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Instytut Pomnik - Centrum Zdrowia DzieckaResearch institute | $248,314,411.89 | czd.pl | |
| Sieć Badawcza Łukasiewicz-Instytut LotnictwaResearch institute | $113,087,646.85 | ilot.lukasiewicz.gov.pl | |
| Narodowe Centrum Badań JądrowychResearch institute | $107,421,404.09 | ncbj.gov.pl | |
| Instytut Matki i DzieckaResearch institute | $87,252,464.05 | imid.med.pl | |
| Instytut Meteorologii I Gospodarki Wodnej - Państwowy Instytut BadawczyResearch institute | $85,385,001.94 | imgw.pl | |
| Narodowy Instytut Geriatrii,Reumatologii I Rehabilitacji Im. Prof. Dr Hab. Med. Eleonory ReicherResearch institute | $56,394,032.20 | spartanska.pl | |
| Państwowy Instytut Geologiczny - Państwowy Instytut BadawczyResearch institute | $52,941,621.28 | pgi.gov.pl |
Change history
| Date | Event |
|---|---|
| 2015-12-29 | Address change (Postępu 18, 02-676, Warszawa → Ul. Postępu 14, 02-676, Warszawa) |
| 2007-01-02 | Address change (Domaniewska 41, 02-672, Warszawa → Postępu 18, 02-676, Warszawa) |
| 2003-11-25 | Share capital change (50,000.00 PLN → 2,000,000.00 PLN) |
| 2003-10-09 | Address change (Mineralna 15, 02-274, Warszawa → Domaniewska 41, 02-672, Warszawa) |
| 2002-08-19 | Address change (Krucza 16/22, 00-526, Warszawa → Mineralna 15, 02-274, Warszawa) |
FAQ
Last updated: 2026-07-12